Suite 1300
Salt Lake City, UT 84111
Block-1 3rd Floor, Perungudi Bypass Rd, Perungudi,
Chennai - 600096
MGR Main Rd,
Perungudi, Chennai - 600096
Villupuram,
Tamil Nadu – 605602
Oncology Billing for Hospitals
Clinical Service Line - Medical & Radiation Oncology
Chemotherapy J-code billing, wastage capture, 340B compliance, infusion accuracy, trial segregation, and prior auth at scale for cancer centers avoiding revenue leakage
$200B+
US Cancer Care Spend
40%+
Oncology Claims Denied
$500M+
340B Savings Potential
HRSA 340B data
Oncology is a revenue cycle, not just a clinical service line
Why oncology revenue cycle is different?
Six dimensions where standard RCM falls short in cancer care
High-Cost Drug Reimbursement Risk
A mis-coded J-code in high-volume infusion can cause major revenue loss. With costly oncology drugs, accuracy in units, route, and NDC directly determines margin and compliance exposure.
Drug Wastage Revenue Opportunity
Modifier JW is used to bill unused portions of single-dose vials and is often undercoded. Accurate wastage capture meets CMS rules and supports ongoing revenue recovery.
Prior Authorization at Every Cycle
Most payers and MA plans require PA for chemo regimens and cycles. High-volume infusion centers face constant authorization pressure impacting cash flow and access
340B Compliance Complexity
Split-billing must clearly identify 340B drugs (JG) and non-340B drugs (TB). Incorrect modifier use creates OIG audit risk and overpayment liability, putting 340B financial benefit at risk.
Clinical Trial Billing Segregation
Medicare Coverage Analysis must precede each trial. Errors in routine vs research cost segregation cause non-payment or False Claims Act risk. Both require expertise to prevent
Continuous Coding Environment
FDA approvals outpace J-code assignment, driving frequent NOC billing, quarterly code updates, and payer policy changes, requiring coders with dedicated oncology expertise.
Key RCM challenges
Where oncology revenue leaks and where AnnexMed intervenes ?
Chemo J-Code & Wastage
Hundreds of oncology drugs have unique HCPCS J-codes. Accurate dosage, unit conversion, NDC reporting, route modifiers, and JW wastage capture are required on every claim. Errors at scale cause major revenue loss and compliance risk in high-cost drug billing.
Prior Authorization at Every Treatment Cycle
Commercial and MA plans require PA for each chemotherapy regimen and often each cycle. High-volume infusion centers managing many patients across regimens face constant authorization pressure, directly impacting treatment continuity and cash flow.
340B Split-Billing Compliance
340B hospitals must separate billing for 340B drugs (JG) and non-340B (TB). Incorrect modifiers create OIG audit risk and overpayment liability. Accurate split-billing protects and monetizes program savings, making it a critical financial performance issue, not just compliance.
Clinical Trial Billing Segregation
Medicare Coverage Analysis must precede each trial to define routine care vs research costs. Errors cause non-payment or False Claims Act risk. Correct trial billing needs protocol-specific expertise and meticulous documentation to ensure compliance and protect revenue.
Radiation Oncology Billing Complexity
IMRT, SBRT, IGRT, proton therapy, and brachytherapy have distinct CPT frameworks with technical and professional components. Simulation, planning, dosimetry, and delivery are separately billable. Incorrect billing misstates costs and reduces reimbursement.
New Drug Coding Lag & NOC Billing
FDA approvals outpace HCPCS J-code assignment, so new oncology drugs use NOC codes (J9999/C9399) with full drug name, NDC, dosage, and route documentation. This process is prone to payer disputes and delays without specialized oncology billing expertise.
Enhancing Oncology Model (EOM) Reporting
CMS EOM replaces OCM with stricter quality reporting, patient navigation documentation, and care plan compliance. Practices must maintain structured EOM reporting alongside FFS claims, adding operational load without reimbursement unless managed efficiently.
Infusion & Administration Charge Capture
Chemotherapy, hydration, and therapeutic infusion services require precise CPT selection, time-based billing, and correct sequencing. Missed units, incorrect hierarchy, or gaps lead to underbilling, denials, and compliance risk across high-volume infusion programs.
Clinical services offered by AnnexMed
Specialized RCM services for oncology & cancer center programs
AnnexMed provides the following specialized RCM services for oncology facilities and cancer center programs:
Chemo J-Code & Wastage
Complete chemo billing across HCPCS J-codes with dosage, units, NDC, route modifiers, JW wastage and JZ reporting, plus accurate NOC billing for newly approved oncology drugs to avoid denials.
Oncology PA Management
Complete chemotherapy billing across HCPCS J-codes with dosage, units, NDC, route modifiers, JW wastage and JZ reporting, plus NOC billing for new drugs with full documentation to prevent denials.
340B Program Split-Billing
Split-billing with correct JG/TB use, 340B vs non-340B identification, audit documentation, and quarterly accuracy reviews to protect savings and ensure OIG compliance
Infusion Center Administration Billing
Drug admin CPT coding across infusion hierarchy: first hour, addl hours, pushes, injections, with NCCI compliance, payer rules, and audits to find underbilled encounters and sequences
Radiation Oncology Billing
TC/26 billing for IMRT, SBRT, IGRT, brachytherapy, proton therapy, covering simulation, planning, dosimetry, delivery, with coverage checks and documentation review for capture
Clinical Trial Billing Compliance
Coverage Analysis review, routine vs research cost segregation, Q0/Q1 use, and documentation to prevent denials and FCA risk; protocol billing ensures coverage from claim
Bone Marrow Transplant Billing
BMT facility and professional billing with regimen coding, transplant billing, and post-care management, ensuring correct DRG, sequencing, and coordination across transplant types
Surgical Oncology Billing
Oncology surgical billing with CDI for cancer DRGs, coordination with pathology billing, and post-op coding, ensuring full charge capture and correct payer classification for resections.
EOM / OCM Reporting Support
EOM reporting for participants: quality metrics, care plan compliance, patient navigation, and 24/7 access, managed with FFS billing by one RCM partner, without added admin burden.
Key billing & coding highlights
Oncology billing & AnnexMed approach
Billing Dimension
Detail & AnnexMed Approach
Claim Form
UB-04 (infusion facility / hospital outpatient); CMS-1500 (medical oncologist professional component)
Drug Billing
HCPCS J-codes (J0000–J9999); NDC required on drug claims; units = dosage ÷ J-code unit size; HCPCS updates monitored.
Drug Wastage
Modifier JW = unused portion of single-dose vial billed; modifier JZ = no wastage; both required for compliance.
NOC Billing
J9999 / C9399 for newly approved agents without J-codes; drug name, dosage, and route required to avoid rejection.
Administration Codes
CPT 96401–96549; infusion hierarchy: first hour, additional, push, injection, with bundling compliance.
340B Modifiers
JG = 340B-purchased drug; TB = non-340B drug, required on claims for hospitals; documentation maintained.
Radiation CPTs
77300–77799 (technical component); 77XX (physician planning), separate TC/26 modifier billing for each radiation episode.
Clinical Trial Modifiers
Q0 = routine clinical trial service; Q1 = medically necessary service in a trial patient, required before each trial.
EOM Requirements
Monthly care plan and clinical access documentation required for EOM participation, tracked alongside billing.
Top Denial Types
PA failure, NDC error, JW omission, 340B modifier dispute, infusion hierarchy sequencing, radiation component mismatch.
Oncology revenue performance
Cancer center financial outcomes
Drug Reimbursement
Improve drug reimbursement with J-code, NDC, and NOC accuracy
Drug Wastage Capture
JW audits recover wastage and prevent future revenue loss
Infusion Charge Capture
Accurate infusion coding captures all admin services
Chemo Denial Reduction
Proactive PA reduces denials and speeds reimbursement
340B Program Value
JG/TB workflows protect 340B savings and compliance
Revenue Integrity
Trial and radiation billing prevent FCA audit risk
Why AnnexMed for oncology revenue cycle?
J-Code & Quarterly Update Expertise
AnnexMed oncology billing stays current via HCPCS training, ensuring new drug codes are applied before claim, protecting reimbursement accuracy on agents from day one
Drug Wastage Revenue Recovery
Our JW wastage program captures revenue. Retrospective audits find wastage, and prospective workflows protect revenue across single-dose administrations.
PA Pipeline Management
Our PA system tracks auth status by patient, regimen, cycle, and payer, giving real-time visibility into the PA pipeline and preventing treatment delays from authorization gaps
Proactive 340B Compliance
AnnexMed ensures 340B compliance with split billing, OIG-grade documentation, and reviews, keeping clients ahead of audits and preserving program savings
Clinical Trial Billing Protection
AnnexMed provides clinical trial billing compliance with Coverage Analysis review, routine vs research cost segregation, and correct Q0/Q1 use to prevent denials and False Claims Act risk across protocols.
EOM Reporting Alongside FFS Billing
AnnexMed manages EOM reporting with FFS billing, giving oncology programs one partner for revenue cycle operations, quality compliance, and alternative payment participation without admin burden
Dedicated Oncology Account Specialists
Dedicated oncology RCM specialist provides account management, strategic oversight, proactive denial analysis, and quarterly revenue integrity reviews from day one of engagement.
Ready to optimize your oncology revenue cycle?
Trusted by 100+ Healthcare Providers | AAPC, AHIMA & AAHAM Certified | SOC 2 Type II | All 50 States
Case Studies
See the impact we deliver
Discover how AnnexMed reduces denials, accelerates reimbursements, and strengthens financial performance. Backed by measurable outcomes and proven RCM expertise, we deliver operational excellence, revenue stability, and sustainable growth you can trust.
Client Voices
See how our clients succeed
Proven RCM expertise. Delivered at scale.
For over 20 years, AnnexMed has delivered RCM solutions nationwide, combining expert billing, coding, and AR support to drive measurable results and growth.
- 20+ years of proven healthcare RCM experience
- 2,000+ professionals supporting billing, coding & AR
- 500+ certified coders across multiple specialties
- 99%+ compliance with HIPAA and security standards
- All 50 states served with consistent, scalable operations
